The Prevalence of Atrial Fibrillation among Acute Medical Admissions in Kuwait

Ridha, Mustafa; Amin, Amin Al-Sayed; Saleh, Salhamoud A.; Cherian, Boby; Al-Kandari, Fawziah; Redha, Faridah; Jamal, Khalid; Bitar, Zouheir

doi:10.1159/000084628

Cited by 7 publications

(8 citation statements)

References 30 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…18 There has been recent increased interest in AF because of the expected rise in its prevalence, the greater appreciation of its serious outcomes, and the development of new anticoagulant and antiarrhythmic medications for its management. 1,3,4,9 -13 Gulf SAFE is the first prospective, multinational, observational study of AF in the Arab Middle East.…”

Section: Discussionmentioning

confidence: 99%

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)

Zubaid

Rashed

Alsheikh‐Ali

et al. 2011

Circ: Cardiovascular Quality and Outcomes

View full text Add to dashboard Cite

Background— Atrial fibrillation (AF) is the most common serious cardiac arrhythmia, and its prevalence is expected to increase. There is lack of data about patient characteristics, practice patterns, and outcomes of AF in the Arab Middle East. Methods and Results— The Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) is a prospective, observational registry of patients with AF with a 12-month follow-up. The registry was emergency room based. Between October 2009 and June 2010, 2043 consecutive patients with AF were enrolled from 23 hospitals in 6 Middle Eastern Gulf countries. Data were collected on a standardized case report form and entered online. Data collected included patient demographics, medical history, type of AF, treatment, and outcome of emergency room visit. If patients were admitted, details of their treatment, investigations, and outcomes during hospital stay were collected. Completion of 12-month follow-up is expected by July 2011. The mean age was 57 years, and 52% were men. The most common concomitant condition was hypertension, present in 1072 (52%) patients. At enrollment, 28% of patients had a history of coronary artery disease, 30% had diabetes, and 16% had rheumatic valve disease. History of stroke and transient ischemic attacks were reported in 9% and 4% of patients, respectively. The most common type of AF, first attack AF, occurred in 37%, whereas 19% of patients had lone AF. Conclusions— Gulf SAFE will provide valuable insights into AF management and outcomes in the Gulf region of the Middle East.

show abstract

Section: Discussionmentioning

confidence: 99%

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)

Zubaid

Rashed

Alsheikh‐Ali

et al. 2011

Circ: Cardiovascular Quality and Outcomes

View full text Add to dashboard Cite

show abstract

“…Little has been published regarding the effect of AF on subsequent development of CE, although these conditions are often comorbid [18,38], and the reverse relationship -an effect of CE on subsequent development of AF -has been observed in longitudinal studies [17,21]. The present longitudinal study is, to our knowledge, the first to show that AF predisposes towards a subsequent diagnosis of CE.…”

Section: Discussionmentioning

confidence: 59%

Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis

Ruigómez¹,

Johansson²,

Wallander³

et al. 2009

International Journal of Cardiology

View full text Add to dashboard Cite

“…Limited data on NVAF-associated thromboembolism specific to the MENA region suggest the 1-year rate of stroke or TIA in patients admitted to the hospital with AF is higher (4.2%) [11] than that in Western countries (0.5–2%) [12], [13], [14]. Adherence to antithrombotic guidelines in a European study was significantly correlated with better outcomes with respect to mortality, thromboembolism and bleeding [15].…”

Section: Resultsmentioning

confidence: 95%

Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa

Hersi

Alhebaishi

Hamoui³

et al. 2018

Journal of the Saudi Heart Association

View full text Add to dashboard Cite

Clinical guidelines for the prevention of stroke in patients with nonvalvular atrial fibrillation (NVAF) are available from several international cardiology associations. Patients with NVAF in the Middle East and North Africa (MENA) region present unique challenges and opportunities related to differences in geography, practice patterns, and patient demographics that are as yet unaddressed in practice guidelines. This review aims to offer a practical perspective on the management of NVAF in patients in MENA and draws on evidence-based guidelines as well as real-world evidence and expert opinion. The literature was searched for relevant original research articles, systematic reviews, meta-analyses, and guideline recommendations addressing the prevention of stroke in patients with NVAF with a focus on issues relevant to the MENA region. Guideline recommendations, best practices, and expert opinion were discussed and agreed on by a working group consisting of cardiologists from across the MENA region. The incidence of stroke secondary to atrial fibrillation in patients across the MENA region is higher than rates reported globally, and this might be attributed to a higher incidence of vascular risk factors and underuse of anticoagulants in patients in the MENA. The available evidence supports the established role of non-vitamin K antagonist oral anticoagulants (NOACs) in the prevention of stroke in patients with NVAF. There is a consistent body of clinical trial and real-world evidence supporting their efficacy for stroke prevention in NVAF, with more favorable bleeding risk profiles relative to vitamin K antagonists, such that guidelines now recommend the use of NOACs in preference over vitamin K antagonists. There are important opportunities to improve the management of NVAF outcomes for patients with NVAF by applying evidence-based guidelines for stroke prevention. Growing experience with NOACs in the MENA region will help guide patient selection and elucidate optimal dosing strategies to maximize the clinical benefits of the NOACs.

show abstract

The Prevalence of Atrial Fibrillation among Acute Medical Admissions in Kuwait

Cited by 7 publications

References 30 publications

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)

Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis

Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa

Contact Info

Product

Resources

About